Class IIReported 2026-01-14

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.

Recalled by Imprimis NJOF, LLC

Reason for Recall

Presence of particulate matter - Glass like particles.

Recall Number

D-0250-2026

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-12-18

Reported

2026-01-14

Distribution

U.S Nationwide

Code Info

Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.